Macro Bank Inc.

BMA
About the company

Banco Macro S.A. provides various banking products and services to retail and corporate customers in Argentina. It offers various retail banking products and services, such as savings and checking accounts, time deposits, credit and debit cards, consumer finance loans, mortgage loans, automobile loans, overdrafts, credit-related services, home and car insurance coverage, tax collection, utility payments, automated teller machines, and money transfers.

Country: ArgentinaPrice: $56.86Market Cap: $3.6B

Investment snapshot

19%positive consensus
Scored 1d ago

Positive

3

BUY / PASS

Neutral / negative

7 / 6

NEUTRAL / FAIL

Median fair value

$17.51

-69.2% vs price

Models with upside

3 / 16

Positive margin of safety

Strongest signal

9 of 10 pass — Buffett objects

Key risk

15 of 16 flag BMA's profitability — Graham, Buffett, Lynch +12 more

Framework analysis

VerdictMeaning
BUYPositive purchase signal: the framework's buy requirements are met.
PASSThe company clears the framework's checklist or screen, but the framework does not produce a buy signal. For valuation frameworks this often means margin of safety is missing, insufficient, or unavailable; some screen-only frameworks have no intrinsic-value BUY state.
NEUTRALNeither a positive nor negative conclusion. It does not mean to hold an existing position.
FAILThe company does not clear the framework's requirements.
RankedRanked strategies do not use PASS: selected cohort is BUY, outside the cohort is FAIL, and unranked is NEUTRAL.

Current investor scores use trailing 12-month flows and the latest balance sheet where supported. Multi-year and EPS tests retain annual history; each framework shows its financial basis below. Intrinsic values use annual financials.

MetricGraham

Defensive Value

Buffett

Quality Compounder

Lynch

GARP

Piotroski

F-Score

Dreman

Contrarian Value

Munger

Quality Focus

Pabrai

Dhandho Framework

Akre

Three-Legged Stool

Marks

Risk-Aware Value

Ackman

Activist Value

Templeton

Global Bargain Hunter

Sleep

Scale Economies Shared

Asness

Systematic Factors

Neff

Low-P/E Total Return

Schloss

Asset-Value Discipline

O'Shaughnessy

Systematic Factor Composite

VerdictFAILFAILFAILNEUTRALPASSNEUTRALNEUTRALFAILNEUTRALFAILPASSPASSNEUTRALFAILNEUTRALNEUTRAL
Score
AnalysisChecking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…
Intrinsic Value (annual)N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Margin of SafetyN/A+6.5%N/AN/AN/A+80.4%-26.4%+89.9%N/AN/AN/AN/AN/AN/AN/AN/A
Financial Basis

Annual history · FY 2024

Latest source filing: 2025-04-21

Score computed: 2026-11-14

Annual history · FY 2024

Latest source filing: 2025-04-21

Score computed: 2026-11-14

Annual history · FY 2024

Latest source filing: 2025-04-21

Score computed: 2026-11-14

Annual history · FY 2024

Latest source filing: 2025-04-21

Score computed: 2026-11-14

Annual history · FY 2024 · Market data at 2026-11-01

Latest source filing: 2025-04-21

Score computed: 2026-11-14

Qualitative assessment · Annual history · FY 2024

Latest source filing: 2025-04-21

Score computed: 2026-11-14

Qualitative assessment · Annual history · FY 2024

Latest source filing: 2025-04-21

Score computed: 2026-11-14

Annual history · FY 2024 · Qualitative assessment

Latest source filing: 2025-04-21

Score computed: 2026-11-14

Annual history · FY 2024 · Qualitative assessment

Latest source filing: 2025-04-21

Score computed: 2026-11-14

Annual history · FY 2024 · Market data at 2026-11-01

Latest source filing: 2025-04-21

Score computed: 2026-11-14

Annual history · FY 2024 · Price history 2025-01-01–2026-11-01

Latest source filing: 2025-04-21

Score computed: 2026-11-14

Annual history · FY 2024 · Qualitative assessment

Latest source filing: 2025-04-21

Score computed: 2026-11-14

Annual history · FY 2024 · Price history 2025-01-01–2026-11-01

Latest source filing: 2025-04-21

Score computed: 2026-11-14

Annual history · FY 2024

Latest source filing: 2025-04-21

Score computed: 2026-11-14

Annual history · FY 2024

Latest source filing: 2025-04-21

Score computed: 2026-11-14

Annual history · FY 2024 · Price history 2025-01-01–2026-11-01

Latest source filing: 2025-04-21

Score computed: 2026-11-14

Where It Passes

  • Cash Flow90% pass✓ 11✗ 1▾

    9 of 10 pass — Buffett objects

    Free Cash Flow Proxy$328.9M
    ✗BuffettPositive and growing
    FCF Positive and Growing$1.8B
    ✓LynchPositive and growing
    Operating Cash Flow$1.9B
    ✓PiotroskiCFO > 0
    (CFO / Total Assets) vs ROACFO/Assets=13.82%, ROA=2.25%
    ✓PiotroskiCFO/Assets > ROA
    Price / (CFO / Shares)1.9x
    ✓Dreman< 8x
    P/E or FCF YieldFCF Yield=50.1%
    ✓PabraiP/E < 15 or FCF Yield > 10%
    FCF Positive6/8 years FCF positive
    ✓MarksPositive FCF in majority of recent years
    (OCF - CapEx) / Market Cap50.1%
    ✓Ackman>= 4%
    Price / FCF per Share2.0x
    ✓Ackman<= 25
    Positive Operating Cash Flow frequency6/8 years positive
    ✓SleepPositive OCF in >= 70% of available years
    Operating Cash Flow - Capital Expenditures$1.8B
    ✓Neff> $0 (app proxy for a strong fundamental case)
    (Operating cash flow - capex) / market capitalization+50.09%; #101/4519 (top 2.2%)
    ✓OshaughnessyTop 10% of eligible cross-section
  • Debt & Leverage75% pass✓ 4✗ 1▾

    3 of 4 pass — Schloss objects

    LT Debt / Total Assets Change0.00% -> 0.00%
    ✓PiotroskiDecreased YoY
    Total Debt / Shareholders' Equity0
    ✓Templeton< 1.0 (fixed cap; proxy for below-sector-median leverage)✓SchlossD/E < 1.00x
    Negative debt-to-equity (higher means less debt)-0.0035; #461/4210 (top 11.0%)
    ✓AsnessTop 30% of eligible cross-section
    Current Assets / Current Liabilities
    ✗SchlossCurrent ratio >= 1.50x (app cutoff)
  • Valuation models75% pass✓ 3✗ 1▾

    Models split on BMA at $56.86 — fair values range $4.50–$56.06

    Buffett fair value$6.08
    ✓Buffett+6.5% margin vs $56.86
    Munger fair value$28.94
    ✓Munger+80.4% margin vs $56.86
    Pabrai fair value$4.50
    ✗Pabrai-26.4% margin vs $56.86
    Akre fair value$56.06
    ✓Akre+89.9% margin vs $56.86

Where It Falls Short

  • Profitability6% pass✓ 8✗ 27▾

    15 of 16 flag BMA's profitability — Graham, Buffett, Lynch +12 more

    Net income / market capitalization+8.68%; #859/6340 (top 13.5%)
    ✓AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-section
    Positive EPS (10 years)0/9 years positive
    ✗GrahamPositive EPS every year for 10 years
    EPS Growth (3-yr avg, 10-yr window)
    ✗Graham>= 33% growth
    Net Income Positive (10+ years)7/9 years positive
    ✗BuffettPositive every year for 10+ years
    ROE (up to 5-year arithmetic mean)23.5%
    ✓Buffett> 15% arithmetic mean (app rule)
    Operating Margin (10-yr trend)
    ✗BuffettStable or rising over 10 years
    Free Cash Flow Proxy$328.9M
    ✗BuffettPositive and growing
    Earnings Variance (10-yr CoV)
    ✗BuffettCoV < 0.3
    Retained Earnings Effectiveness
    ✗Buffett$1 retained -> > $1 market value created
    Basic earnings-growth PEG (dividends excluded)
    ✗Lynch< 1.0 (ideally < 0.5)
    3-5 Year EPS CAGR
    ✗Lynch15-30% (Fast Grower); > 0% to pass
    ROE8.0%
    ✗Lynch> 15%
    Net Income / Total Assets2.25%
    ✓PiotroskiROA > 0
    ROA Change YoY8.66% -> 2.25% (delta: -6.42%)
    ✗PiotroskiCurrent ROA > Prior ROA
    (CFO / Total Assets) vs ROACFO/Assets=13.82%, ROA=2.25%
    ✓PiotroskiCFO/Assets > ROA
    Pre-Tax Income / Revenue
    ✗Dreman>= 8%
    Net Income / Shareholders' Equity8.0%
    ✗Dreman> 12%
    Return on Equity8.0%
    ✗Munger> 15%✗AkreROE > 20% (3-year avg)
    Margin of SafetyP/TBV=0.9x
    ✓PabraiP/TBV < 1.5 or P/E < 15
    ROE (high and growing)FY2022: ROE=17.3%; FY2023: ROE=28.6%; FY2024: ROE=8.0%
    ✗AkreLatest 3 consecutive FYs: ROE > 15% in each
    Discount to Intrinsic Value
    ✗Marks>= 20% below intrinsic value
    Positive Net Income Frequency7/8 years positive
    ✓MarksPositive net income in >= 7 of last 10 years
    Operating Income / Revenue
    ✗Ackman>= 15%
    Net Income / Shareholders Equity8.0%
    ✗Ackman>= 15%
    5-Year EPS CAGR
    ✗Templeton> 0% (5-year EPS CAGR)
    Operating Margin Trend
    ✗TempletonNon-negative operating-margin trend over 3 years
    Revenue growth vs. gross and operating margin trend
    ✗SleepRevenue rising; gross margin flat or falling; operating margin holding
    ROE (5-year)4/5 years above 12% (latest 8.0%)
    ✓SleepROE > 12% in a majority of years
    Gross profit / total assets
    ✗AsnessTop 30% of eligible cross-section
    Net income / positive book equity+8.04%; #2091/5226 (top 40.0%)
    ✗AsnessTop 30% of eligible cross-section
    Negative 5-year standard deviation of ROA-0.0226; #1583/5884 (top 26.9%)
    ✓AsnessTop 30% of eligible cross-section
    3-5 Year Diluted EPS CAGR
    ✗Neff7%-20% annualized
    Positive Diluted-EPS Years
    ✗Schloss>= 70% positive over 5-10 observed years (app rule)
  • Growth13% pass✓ 1✗ 11▾

    7 of 8 flag BMA's growth — Graham, Lynch, Dreman +4 more

    EPS Growth (3-yr avg, 10-yr window)
    ✗Graham>= 33% growth
    Basic earnings-growth PEG (dividends excluded)
    ✗Lynch< 1.0 (ideally < 0.5)
    3-5 Year EPS CAGR
    ✗Lynch15-30% (Fast Grower); > 0% to pass
    EPS Growth Direction
    ✗DremanPositive over recent years
    EPS CAGR
    ✗Dreman> 5% annualized
    Positive Net Income Frequency7/8 years positive
    ✓MarksPositive net income in >= 7 of last 10 years
    3yr Median Revenue Growth
    ✗Ackman>= 5%
    Positive EPS Growth Frequency
    ✗AckmanPositive EPS growth in >= 3 of last 5 years
    5-Year EPS CAGR
    ✗Templeton> 0% (5-year EPS CAGR)
    Revenue growth vs. gross and operating margin trend
    ✗SleepRevenue rising; gross margin flat or falling; operating margin holding
    5-year Revenue CAGR
    ✗SleepCAGR > 7%
    3-5 Year Diluted EPS CAGR
    ✗Neff7%-20% annualized
  • Valuation33% pass✓ 13✗ 13▾

    8 of 12 flag BMA's valuation — Graham, Lynch, Dreman +5 more

    Price / Book Value per Share0.9x
    ✓Templeton< 1.5x✗SchlossP/B <= 0.80x (app cutoff)
    Net income / market capitalization+8.68%; #859/6340 (top 13.5%)
    ✓AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-section
    Price / 3-yr avg EPS
    ✗Graham<= 15x
    Price-to-Tangible-Book Ratio0.9x
    ✓Graham<= 1.5x
    P/E x P/TBV
    ✗Graham<= 22.5
    Basic earnings-growth PEG (dividends excluded)
    ✗Lynch< 1.0 (ideally < 0.5)
    Price / EPS
    ✗Dreman< 12x✗Templeton< 12x (fixed ceiling; proxy for the market's cheapest 40%)
    Price / (CFO / Shares)1.9x
    ✓Dreman< 8x
    Price / Tangible Book Value per Share0.9x
    ✓Dreman< 1.2x✓SchlossP/TBV <= 1.00x (app cutoff)
    Valuation ReasonablenessOE Yield=9.0%
    ✓MungerP/E < 25 or Owner Earnings Yield > 5%
    P/E or FCF YieldFCF Yield=50.1%
    ✓PabraiP/E < 15 or FCF Yield > 10%
    P/B or P/E vs. Historical AverageP/B=0.9x
    ✓MarksP/E < 15 or P/B < 2.0
    Discount to Intrinsic Value
    ✗Marks>= 20% below intrinsic value
    Price / FCF per Share2.0x
    ✓Ackman<= 25
    Price vs. Trailing Low134% of trailing low ($4.23)
    ✗Templeton<= 120% of trailing low (certified split-adjusted live window)
    Positive book equity / market capitalization+1.0803; #1345/6449 (top 20.9%)
    ✓AsnessTop 30% of eligible cross-section
    Price / Diluted EPS
    ✗NeffP/E <= 15x (app proxy for a P/E 40%-60% below the market)
    (EPS CAGR % + Dividend Yield %) / P/E
    ✗Neff> 0.7 (Neff's published traditional edge)
    Book Value per Share Change+81.4%
    ✓SchlossLatest BVPS >= earliest BVPS over >= 3 years (app rule)
    Revenue / market capitalization
    ✗OshaughnessyTop 10% of eligible cross-section
    (Operating cash flow - capex) / market capitalization+50.09%; #101/4519 (top 2.2%)
    ✓OshaughnessyTop 10% of eligible cross-section
    Trailing six-month price return through the evaluation date-29.01%; #4379/6202 (top 70.6%)
    ✗OshaughnessyTop 10% of eligible cross-section
  • Efficiency33% pass✓ 1✗ 2▾

    2 of 3 flag BMA's efficiency — Piotroski and Akre

    Revenue / Total Assets Change YoY
    ✗PiotroskiImproved YoY
    Reinvestment Rate x ROIC0.0% (RR=0% x ROIC=8.0%)
    ✗AkreReinvestment Rate * ROIC > 10%
    ROE (5-year)4/5 years above 12% (latest 8.0%)
    ✓SleepROE > 12% in a majority of years
  • Verdicts33% pass✓ 3✗ 6▾

    Split decision: 7 NEUTRAL · 6 FAIL · 3 PASS

    Overall verdict
    ✗GrahamFAIL (1/7)✗BuffettFAIL (1/6)✗LynchFAIL (1/4)•PiotroskiNEUTRAL (F-Score 5)✓DremanPASS (4/9)•MungerNEUTRAL (2/3)•PabraiNEUTRAL (2/3)✗AkreFAIL (0/5)•MarksNEUTRAL (3/4)✗AckmanFAIL (3/8)✓TempletonPASS (4/8)✓SleepPASS (3/6)•AsnessNEUTRAL (Not ranked)✗NeffFAIL (2/6)•SchlossNEUTRAL (4/7)•OshaughnessyNEUTRAL (Not ranked)

Business & financials

Financial snapshot: annual FY 2024. Current investor scores may use newer quarterly data.

Company Profile

Industry: Banking
Size: Mid Cap($3.6B)
Revenue: N/A
Net Income: $315.7M-79.9% YoY

Financial Snapshot

Operating Margin--
Return on Equity8.0%
Debt / Equity0.00
Current Ratio--
Shares Retired0.0% / 0.0% 2y
Sector-adjusted criteria: Bank

Leverage is a bank’s business model and current accounts don’t exist on its balance sheet, so debt and liquidity tests are omitted and tangible book value and ROE replace their industrial analogs.

Shareholder Return

Fiscal 2024

Retired 0.0% of shares last year, 0.0% over two.

Buybacks
—
Dividends
$452.9M

Company Financials

Latest TTM and quarters alongside annual years

TTM sums four consecutive quarters and uses the latest quarter-end balances. Quarter columns show three-month results; annual columns show full-year totals. Growth compares the same period a year earlier. EPS is not added for TTM; full-year ratios are blank for quarters.

MetricFY 2024
Sources
  • 20-F · 2025-04-21
FY 2023
Sources
  • 20-F · 2024-04-29
FY 2022
Sources
  • 20-F · 2023-04-28
FY 2021
Sources
  • 20-F · 2022-04-28
FY 2020
Sources
  • 20-F · 2021-04-29
Market Cap$3.6Bcurrent$18.6Best.$11.2Best.$6.8Best.$6.3Best.
Revenue----------
Operating Income$2.6B↓52%$5.5B↓51%$11.0B↑132%$4.8B↑117%$2.2B
Net Income$315.7M↓80%$1.6B$1.6B↑30%$1.2B↑47%$819.0M
EPS (Diluted)----------
Gross Margin—————
Operating Margin—————
ROE8.0%↓72%28.6%↑65%17.3%↓42%29.7%↓12%33.6%
Total Debt$13.6M↓46%$25.3M↓66%$75.4M↓54%$162.9M↑42%$114.6M
Shareholders' Equity$3.9B↓29%$5.5B↓39%$9.0B↑123%$4.1B↑66%$2.4B
Current Ratio—————
Debt / Equity0.00↓25%0.00↓45%0.01↓79%0.04↓15%0.05
Operating Cash Flow$1.9B↑945%-$229.7M↓101%$19.9B↑741%$2.4B↓37%$3.7B
Free Cash Flow$1.8B↑575%-$383.5M↓102%$18.9B↑848%$2.0B↓45%$3.6B

Score history

Historical Score Timeline

Industry peers

Industry Peers

Similar companies in Banking

BMA vs Peers — Financial Grading

RevenueN/A
Net Income$315.7MBottom 25%
ROE8.0%Bottom 25%
D/E0.00Top 25%
Op. Margin—
Curr. Ratio—
CompanyMarket CapPriceRevenueNet IncomeROED/EOp. MarginCurr. RatioGrahamBuffettLynchPiotroskiDreman
MITSUBISHI UFJ FINANCIAL GROUP INCMUFG$245.7B$21.83$74.2B$10.8B8.8%1.1219.9%—2/71/61/4F-Score 53/9
AMERICAN EXPRESS COAXP$215.0B$320.60$41.3B$10.8B32.4%1.68——2/73/63/4F-Score 43/9
Banco Santander, S.A.SAN$175.9B$12.21—$16.6B12.5%0.02——2/71/62/4F-Score 45/9
BARCLAYS BANK PLCATMP$82.1B$35.04$13.1B$6.3B7.5%0.01——2/71/60/4F-Score 74/9
BARCLAYS PLCBCS$76.0B$22.87$15.0B$9.7B9.2%0.02——1/70/60/4F-Score 72/9
FIRST CITIZENS BANCSHARES INC /DE/FCNCA$25.7B$2324.25$9.5B$2.2B9.9%1.62——5/73/61/4F-Score 52/9
KEYCORP /NEW/KEY$22.7B$21.46$7.5B$1.8B9.0%0.49——2/71/61/4F-Score 64/9
WEBSTER FINANCIAL CORPWBS$12.6B$77.57$2.9B$1.0B10.6%0.0850.7%—2/71/61/4F-Score 72/9